Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Screening for galactosemia
Galactosemia is an inborn error of galactose metabolism caused
by a deficiency of 1 of 3 enzymes: galactose-1-phosphate
uridyltransferase (GALT), galactokinase (GK), and uridine diphosphate
galactose -4-epimerase (UDPGal-4-epimerase). In patients with
galactosemia, consumption of milk products results in exaggerated
plasma galactose concentrations (dietary lactose is metabolized
to glucose and galactose).
The most common cause of galactosemia is deficiency of GALT.
Symptoms of untreated GALT deficiency include failure to thrive,
vomiting, liver disease, cataracts, and developmental delay.
Patients with classic GALT deficiency are at risk of life-threatening
liver and kidney failure and Escherichia coli sepsis in the newborn
period. Because of the poor prognosis of the untreated galactosemic
patient, it is imperative that treatment be instituted early. This led
to the inclusion of GALT deficiency into all newborn screening
programs in the United States. Accordingly, most patients are
diagnosed following a positive newborn screen, but physicians
must still consider this diagnosis in any patient presenting with
liver disease.
Galactosemia is diagnosed by specific enzyme assay when the
clinical presentation is highly suggestive of a specific deficiency
or by screening for abnormally accumulating metabolites, in
particular galactose and galactose-1-phosphate (G-1-P).
The following table indicates which metabolites are elevated
in the various forms of galactosemia as long as the patient is
on a regular, lactose-containing diet:
Galactose G-1-P
Deficiency (plasma/urine) (blood)
Galactokinase Elevated Normal
GALT Elevated Elevated
UDPGal-4- Normal- Elevated
Epimerase Elevated
Molecular testing for the most common galactosemia alleles and
variants is available to confirm the patient's genotype (#84360
"Galactosemia Confirmation Testâ€, #84366 "Galactosemia
Confirmation Test, Bloodâ€).
1-7 days: <5.4 mg/dL
8-14 days: <3.6 mg/dL
>14 days: <2.0 mg/dL
Elevated plasma galactose values are found in individuals with
galactosemia.
When elevated, the specific enzymatic defect should be
determined. In order of probability they are: #8333 "Galactose-1-
Phosphate Uridyltransferase (GALT), Bloodâ€; or #8628 "Galactokinase,
Bloodâ€; galactose-4-epimerase (rare; referral test). #84360
"Galactosemia Confirmation Test, Blood †which includes GALT
and reflexes to molecular testing, is the preferred second-order
diagnostic test.
For monitoring of dietary compliance refer to #80337 "Galactose-1-Phosphate,
(Gal-1-P), Erythrocytes".
1. Holton JB, Walter JH, Tyfield LA: Galactosemia. In The
Metabolic and Molecular Bases of Inherited Disease.
8th edition. Edited by CR Scriver, AL Beaudet, D Valle, et al:
New York, McGraw-Hill Book Company, 2001, pp 1553-1587
2. Prinz W, Meldrum W, Wilkinson L: A simple and rapid
thin-layer chromatographic method for the identification
of urinary carbohydrates. Clin Chim Acta 1978;82:229-232
3. Shin YS: Galactose metabolites and disorders of
galactose metabolism. In Techniques in Diagnostic
Human Biochemical Genetics. Edited by FA Holmes.
New York, Wiley-Liss, 1991, pp 267-283